Trial · NCT02596074
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pharmacodynamics (HPV Viral Load Assessment) | 24 Weeks | Assessment of target lesions by quantitative PCR including HPV genotyping in swabs and biopsies |
| Primary | Pharmacodynamics (Local Immunity Status) | 24 Weeks | Histological changes in immune cells in the mucosa/submucosa |
| Primary | Clinical Assessment (Lesions by RECIST) | 24 Weeks | Efficacy assessment of lesions by RECIST |
| Primary | Clinical Assessment (Percent clearance of Lesions) | 24 Weeks | Efficacy assessment of percent clearance of lesions |
| Primary | Clinical Assessment (Sum of the longest diameter (SLD)) | 24 Weeks | Efficacy assessment of the sum of the longest diameter (SLD)) |
| Primary | Clinical Assessment (Histology) | 24 Weeks | Efficacy assessment of the histology (regression of uVIN to no dysplasia) |
| Secondary | Safety and Tolerability (Adverse Events) | 48 Weeks | Adverse Events will be collected throughout the study |
| Secondary | Safety and Tolerability (Laboratory Safety Testing) | 48 Weeks | Laboratory Samples will be collected throughout the study |
| Secondary | Safety and Tolerability (12-Lead ECGs) | 48 Weeks | 12-Lead ECGs will be performed throughout the study |
| Secondary | Safety and Tolerability (Vital Signs) | 48 Weeks | Vital Signs will be collected throughout the study |
| Secondary | Pharmacokinetics (Area Under the Curve) | 12 Weeks | AUC will be computed |
| Secondary | Pharmacokinetics (Maximum Plasma Concentration) | 12 Weeks | Cmax will be determined |
| Secondary | Pharmacokinetics (Tmax) | 12 Weeks | Tmax will be determined |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02596074/registered